Edmund Tse

1.1k total citations
37 papers, 623 citations indexed

About

Edmund Tse is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Edmund Tse has authored 37 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 20 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Edmund Tse's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (15 papers) and Liver Disease and Transplantation (7 papers). Edmund Tse is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (15 papers) and Liver Disease and Transplantation (7 papers). Edmund Tse collaborates with scholars based in Australia, United States and France. Edmund Tse's co-authors include Annie Wong‐Beringer, Paul M. Beringer, Katherine Stuart, Stephen Pianko, Rafia Bhore, Alexander Thompson, Vincent Leroy, Christophe Hézode, Peter Angus and Jean–Pierre Bronowicki and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Edmund Tse

30 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edmund Tse Australia 11 335 319 217 161 92 37 623
R. McGory United States 10 482 1.4× 391 1.2× 254 1.2× 196 1.2× 93 1.0× 14 783
Jean–Jacques Garaud France 15 717 2.1× 744 2.3× 311 1.4× 222 1.4× 119 1.3× 18 1.2k
Leonor Pou Spain 17 293 0.9× 86 0.3× 454 2.1× 63 0.4× 23 0.3× 29 900
J.C. Cappelleri United States 6 194 0.6× 39 0.1× 44 0.2× 229 1.4× 33 0.4× 57 496
Damien Simoneau France 12 165 0.5× 85 0.3× 120 0.6× 79 0.5× 89 1.0× 17 644
Lauren M. Hynicka United States 10 114 0.3× 41 0.1× 105 0.5× 67 0.4× 25 0.3× 21 317
J. P. Richardet France 9 340 1.0× 308 1.0× 136 0.6× 13 0.1× 60 0.7× 14 529
Brian L. Pearlman United States 18 919 2.7× 1.0k 3.3× 229 1.1× 16 0.1× 22 0.2× 43 1.3k
Trana Hussaini Canada 12 296 0.9× 243 0.8× 155 0.7× 24 0.1× 7 0.1× 47 518
Qiquan Wan China 15 272 0.8× 51 0.2× 85 0.4× 116 0.7× 37 0.4× 56 615

Countries citing papers authored by Edmund Tse

Since Specialization
Citations

This map shows the geographic impact of Edmund Tse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmund Tse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmund Tse more than expected).

Fields of papers citing papers by Edmund Tse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmund Tse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmund Tse. The network helps show where Edmund Tse may publish in the future.

Co-authorship network of co-authors of Edmund Tse

This figure shows the co-authorship network connecting the top 25 collaborators of Edmund Tse. A scholar is included among the top collaborators of Edmund Tse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmund Tse. Edmund Tse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sukocheva, Olga, et al.. (2025). Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives. World Journal of Hepatology. 17(7). 106675–106675. 1 indexed citations
2.
Sukocheva, Olga, et al.. (2025). The tumor suppressor role and epigenetic regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in cancer and tumor microenvironment (TME). Pharmacology & Therapeutics. 268. 108826–108826. 3 indexed citations
3.
Howell, Jess, Jon Emery, Stuart K. Roberts, et al.. (2025). Opportunities to improve surveillance of hepatocellular carcinoma in Australia. The Medical Journal of Australia. 223(2). 61–67.
4.
Lim, Amanda, Olga Sukocheva, Jana Bednarz, et al.. (2025). Impact of Different Modalities of Radiotherapy in Locally Advanced Pancreatic Cancer: A Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology. 40(10). 2413–2424.
5.
6.
7.
McCartney, Erin M., Jeffrey Stewart, Jacqueline A. Richmond, et al.. (2024). Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021–2022. Viruses. 16(12). 1882–1882. 1 indexed citations
8.
Lim, Amanda, Benjamin Crouch, Rohit Joshi, et al.. (2024). The Impact of Combined Chemotherapy and Intra-Tumoural Injection of Phosphorus-32 Microparticles on Vascularity in Locally Advanced Pancreatic Carcinoma. Cancers. 16(19). 3412–3412. 3 indexed citations
9.
Dallavalasa, Siva, Preethi G. Anantharaju, R. Rajalakshmi, et al.. (2024). Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies. Cancers. 16(18). 3211–3211. 8 indexed citations
10.
McCartney, Erin M., Jacqui Richmond, Alan Wigg, et al.. (2024). Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study. Clinical Infectious Diseases. 79(4). 965–973. 4 indexed citations
11.
Manning, Todd, et al.. (2024). Updates in digital shared care: Launching into the 21st century. Australian Journal of General Practice. 53(11). 872–878.
12.
Tse, Edmund, et al.. (2023). The basis and implications of diverging approaches to colorectal adenoma surveillance in the West. Internal Medicine Journal. 53(4). 635–639. 1 indexed citations
13.
Clark, Paul J., Patricia C. Valery, Simone I. Strasser, et al.. (2023). Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care. Journal of Gastroenterology and Hepatology. 39(3). 568–575. 2 indexed citations
14.
Nicoll, Amanda, et al.. (2020). eHealth Technologies for Screening, Diagnosis, and Management of Viral Hepatitis: A Systematic Review. Clinical Gastroenterology and Hepatology. 19(6). 1139–1150.e30. 23 indexed citations
15.
Nicoll, Amanda, Stuart K. Roberts, Joanne Mitchell, et al.. (2019). Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels. Alimentary Pharmacology & Therapeutics. 49(10). 1314–1322. 14 indexed citations
16.
Ramachandran, Jeyamani, Monowar Hossain, Edmund Tse, et al.. (2018). Coordinated care for patients with cirrhosis: fewer liver‐related emergency admissions and improved survival. The Medical Journal of Australia. 209(7). 301–305. 11 indexed citations
17.
Khoo, Anthony & Edmund Tse. (2016). A practical overview of the treatment 
of chronic hepatitis C virus infection.. PubMed. 45(10). 718–720. 3 indexed citations
18.
Tse, Edmund, Karla J. Helbig, Kylie H. Van der Hoek, et al.. (2015). Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon. Journal of Interferon & Cytokine Research. 35(5). 392–400. 15 indexed citations
19.
Wong‐Beringer, Annie, et al.. (2010). Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. International Journal of Antimicrobial Agents. 37(2). 95–101. 136 indexed citations
20.
Hui, Ka Kit, et al.. (1991). Interaction of berberine with human platelet α2 adrenoceptors. Life Sciences. 49(4). 315–324. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. McGory Breakdown of academic impact, for papers by Jean–Jacques Garaud Breakdown of academic impact, for papers by Leonor Pou Breakdown of academic impact, for papers by J.C. Cappelleri Breakdown of academic impact, for papers by Damien Simoneau Breakdown of academic impact, for papers by Lauren M. Hynicka Breakdown of academic impact, for papers by J. P. Richardet Breakdown of academic impact, for papers by Brian L. Pearlman Breakdown of academic impact, for papers by Trana Hussaini Breakdown of academic impact, for papers by Qiquan Wan
Rankless by CCL
2026